14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $26.98 $26.98 Thursday, 8th Jun 2023 MYOV stock ended at $26.98. During the day the stock fluctuated 0% from a day low at $26.98 to a day high of $26.98.
90 days $26.98 $26.98
52 weeks $9.81 $27.06

Historical Myovant Sciences Ltd prices

Date Open High Low Close Volume
Aug 22, 2022 $17.12 $17.60 $17.03 $17.23 528 688
Aug 19, 2022 $17.94 $18.01 $17.40 $17.51 513 670
Aug 18, 2022 $18.08 $18.25 $17.57 $18.23 594 975
Aug 17, 2022 $17.24 $18.33 $17.21 $18.12 1 083 028
Aug 16, 2022 $18.14 $18.67 $17.64 $17.65 930 649
Aug 15, 2022 $18.23 $18.57 $17.76 $18.40 541 208
Aug 12, 2022 $17.75 $18.84 $17.75 $18.49 905 404
Aug 11, 2022 $17.65 $18.08 $17.28 $17.70 1 308 986
Aug 10, 2022 $16.98 $17.68 $16.25 $17.60 981 170
Aug 09, 2022 $16.17 $16.94 $15.55 $16.68 1 395 551
Aug 08, 2022 $16.41 $17.50 $15.39 $15.67 2 260 115
Aug 05, 2022 $14.41 $15.27 $14.14 $15.12 715 444
Aug 04, 2022 $14.30 $14.94 $13.91 $14.65 892 017
Aug 03, 2022 $14.12 $14.75 $13.88 $14.18 645 714
Aug 02, 2022 $13.32 $13.99 $13.32 $13.79 471 150
Aug 01, 2022 $13.12 $13.83 $12.86 $13.23 803 757
Jul 29, 2022 $13.14 $13.29 $12.73 $13.08 833 370
Jul 28, 2022 $12.78 $13.74 $12.72 $13.21 1 057 405
Jul 27, 2022 $12.16 $12.27 $11.51 $12.23 823 137
Jul 26, 2022 $11.64 $12.26 $11.54 $11.81 435 813
Jul 25, 2022 $11.70 $11.96 $11.33 $11.77 357 967
Jul 22, 2022 $12.07 $12.26 $11.57 $11.60 570 163
Jul 21, 2022 $12.23 $12.52 $11.80 $12.07 724 836
Jul 20, 2022 $12.91 $13.35 $12.26 $12.26 708 128
Jul 19, 2022 $12.48 $13.20 $12.42 $12.79 811 411
Click to get the best stock tips daily for free!

About Myovant Sciences Ltd

Myovant Sciences Ltd Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, whic... MYOV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT